Chris H. Takimoto - Director at ALX ONCOLOGY HOLDINGS INC

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Chris H. Takimoto since 27 Aug 2025

Reported holdings for Chris H. Takimoto in ALX ONCOLOGY HOLDINGS INC

Form 4 holding Director

ALX ONCOLOGY HOLDINGS INC

Security class
Common Stock (right to buy)
Shares / value
40,400
Estimated value
$72,720
Report date
21 Jan 2025
Price
$1.80
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Chris H. Takimoto in ALX ONCOLOGY HOLDINGS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .